Sigma sleep drug
April 21, 2010
SIGMA has received approval to
market its prolonged release
melatonin insomnia medication,
Circadin, in Australia.
Not currently available on the
PBS, Circadin is the first melatonin
receptor agonist to be registered in
Australia.
According to its randomised
double-blind, placebo-controlled
multi-centre test results, Circadin
was found to improve sleep quality
and morning alertness with no
dependence or withdrawal side effects.
Approved for use in patients aged
over 55yrs for a period of up to
three weeks, testing of Circadin
also found that it improved sleep
onset latency in comparative rates
to some of the most frequently used
sleep medications.
Circadin should be taken oncedaily,
after food and two hours
before sleep.
Approximate patient pricing of
Circadin is $32 for a pack of 21 tablets.
The above article was sent to subscribers in Pharmacy Daily's issue from 21 Apr 10To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 21 Apr 10
